INTRODUCTION
============

Osteoarthritis (OA) is one of the most prevalent chronic diseases affecting the elderly and is a major degenerative disease affecting millions of individuals. The most prominent feature of OA is the progressive destruction of articular cartilage, and it is now accepted that OA is a global disease involving synovial membranes, subchondral bone, and periarticular soft tissues [@B001]. Today, in the search for a cure for OA, the inhibition of the enzymatic degradation of the extracellular matrix (ECM) and the maintenance of the cellular phenotype are two of the major goals in OA research [@B002],[@B003].

Hydrogen peroxide (H~2~O~2~) has a variety of biological effects on various cell types. In chondrocytes, H~2~O~2~ inhibits proteoglycan synthesis and induces the degradation of the ECM [@B004]. H~2~O~2~ is also related to aggrecan degradation in bovine articular chondrocytes [@B005]. H~2~O~2~ induces the expression of the inflammatory cytokines interleukin (IL)-1β and tumor necrosis factor (TNF)-α, which exert negative effects on the expression of matrix metalloproteinases (MMPs) and transforming growth factor (TGF)-β1 [@B006]. Furthermore, H~2~O~2~ may produce reactive oxygen species (ROS) and nitric oxygen (NO) species in addition to inducing the apoptosis of chondrocytes [@B007]. Thus, H~2~O~2~ may be an important factor involved in the pathology of OA. Free radicals are related to many chronic inflammatory diseases [@B004]. Many studies have shown that free radicals play an important role in the pathology of OA [@B005]-[@B008]. Among the various ROS and NO that exist, H~2~O~2~ is an important intermediate in superoxide anion metabolism. H~2~O~2~ is formed from the superoxide anion by superoxide dismutase and is removed by glutathione peroxidase and catalase [@B009]. Recent studies show that the activity of catalase in OA joints is decreased [@B010] and that the accumulation H~2~O~2~ in arthritic joints is expected [@B011]. Therefore, antioxidants that protect against free radicals such as H~2~O~2~ are valuable for the protection of chondrocytes by blocking the catabolic signaling cascades that are triggered by inflammatory cytokines and free radical stimulation.

Ginseng is a rich source of ginsenosides, and several epidemiological and animal studies have shown that ginseng consumption is associated with health benefits, including the inhibition of inflammation [@B012]. Most of the beneficial health effects of ginseng have been shown to be mediated by most prevalent component, ginsenoside. Ginsenoside influences a number of cellular mechanisms and has been shown to inhibit the activities of IL-1β and TNF-α [@B013]. In addition, ginsenoside Rb~1~ is also an inhibitor of ROS and NO activity and downregulates the levels of several markers of oxidative stress [@B013]. Despite several studies in the literature detailing the antioxidant effects of ginsenoside Rb~1~, the mechanisms underlying protective effects at the chondrocyte cellular level have not been reported. In this study, we evaluated the protective effects of ginsenoside Rb~1~ on rat articular chondrocytes and the molecular mechanisms involved in the protection.

MATERIALS AND METHODS
=====================

Harvesting chondrocytes and establishing cell cultures
------------------------------------------------------

A modified method for harvesting chondrocytes was used as previously described [@B014]. Briefly, chondrocytes were isolated from the articular cartilage of three-week-old male Sprague Dawley rats. Cartilage was removed from animals that were subsequently euthanized by an overdose of anesthesia. The cartilage was cut into thin slices, washed with sterilized phosphate-buffered saline (PBS), and soaked in 5% penicillin--streptomycin-- neomycin (Sigma, St. Louis, MO, USA) for 15 min. The cartilage slices were washed with PBS to remove residual antibiotic solution and digested with 0.02% type II collagenase (Sigma) in Dulbecco's Modified Eagle's Medium (DMEM; HyClone, Logan, UT, USA) for 3 h in a 37℃ water bath. The digested cartilage was collected and centrifuged. The pellet was resuspended in DMEM and filtered through 70-μm nylon mesh. The resultant chondrocytes were cultured in DMEM supplement with 10% fetal bovine serum and 1% penicillin--streptomycin-- neomycin in a 5% CO~2~ incubator at 37℃. All experiments were performed when cells reached confluence within the first passage. Ginsenoside Rb~1~ was purchased from Ambo Institute (Daejeon, Korea).

Cell viability assay
--------------------

The water soluble tetrazolium cell proliferation assay was used to measure cell viability by calculating the quantitative absorbance of formazan using an EZ-Cytox Cell Viability Assay Kit (DAEIL lab, Seoul, Korea). The EZ-Cytox agent is converted into orange formazan by the mitochondria of active cells. The amount of orange product increases with an increase in cell activity and can be quantified using a spectrophotometer. Cells were plated in 96-well plates at a density of 2.0×10^4^ cells per well, incubated for 24 h and treated with various concentrations (25 to 400 μM) of ginsenoside Rb~1~. We then determined whether a 1-hour pretreatment with ginsenoside Rb~1~ (50 or 100 μM) influenced the viability of chondrocytes treated with 500 μM H~2~O~2~ for 24 h. After the incubation period, 10 μL of the kit solution was added to each well, and the cells were incubated for 3 h at 37℃ in 5% CO~2~. The index of cell viability was determined by measuring formazan production with a microplate reader at an absorbance of 480 nm and a reference wavelength of 650 nm.

Enzyme-linked immunosorbent assay
---------------------------------

The concentrations of IL-1β and TNF-α in the supernatants were determined by enzyme-linked immunosorbent assay (ELISA) using a kit (Invitrogen, Carlsbad, USA) according to the manufacturer's instructions. The detection limit of the assay was 1.6 pg/mL.

Intracellular reactive oxygen species assay
-------------------------------------------

The level of intracellular ROS was quantified by fluorescence using dichlorofluorescein diacetate (DCFDA, Invitrogen). Chondrocytes plated in a 48-well plate were left untreated or were pretreated for 1 h with 50 or 100 μM ginsenoside Rb~1~ in the absence or presence of H~2~O~2~, and then the cells were incubated for 0.5 h. After the incubation period, the cells were washed with PBS and stained with 10 μM DCF-DA in PBS for 30 min in the dark. The cells were then washed twice with PBS and extracted with 0.1% Tween-20 in PBS for 10 min at 37℃. Fluorescence was recorded with an excitation wavelength of 490 nm and an emission wavelength of 525 nm.

Nitric oxygen production and activity of inducible nitric oxide synthase
------------------------------------------------------------------------

The concentration of NO was measured by the Griess reaction. A 20 μL sample of culture medium supernatant was mixed with 180 μL of Griess reagent at room temperature for 10 min, and then the absorbance was measured in a microplate reader at 570 nm. The activity of inducible nitric oxide synthase (iNOS) was analyzed by immunoblotting. Briefly, total cell extracts were harvested in radioimmunoprecipitation assay buffer and then centrifuged at 15,000 rpm for 15 min at 4℃. Quantification of the total protein was performed with bicinchoninic acid protein assay reagent (Bio-Rad Laboratories, Hercules, CA, USA). Proteins were resolved with sodium dodecyl sulfate polyacrylamide gel electrophoresis at 10% and transferred to a polyvinylidene difluoride membrane. After blocking in 5% skim milk in PBS with 0.1% Tween-20 (PBS-T), the membrane was incubated with specific primary antibodies for iNOS and β-actin (Cell Signaling, Danvers, MA, USA) diluted 1:1,000 in 1% skim milk in PBS-T overnight at 4℃. After washing, the blots were incubated at room temperature for 1 h with a peroxidase-conjugated goat anti-rabbit IgG secondary antibody (Millipore, Bedford, MA, USA) diluted 1:10,000 in PBS-T. The signals were detected with a SuperSignal West Dura Extended Duration Substrate (Thermo Scientific, San Jose, CA, USA), according to the manufacturer's instructions. Densitometric analysis was conducted directly using the blotted membrane utilizing a ChemiImager analyzer system (Alpha Innotech, San Leandro, CA, USA).

RNA preparation and real-time reverse transcription polymerase chain reaction
-----------------------------------------------------------------------------

Total cellular RNA was precipitated with Ribo EX (GeneAll, Daejeon, Korea) and dissolved in 0.1% diethylpyrocarbonate-treated distilled water. Total RNA (2 μg) was treated with RNase-free DNase (Invitrogen), and first-strand cDNA was generated using the oligo primers provided in a first-strand cDNA synthesis kit, (Maxime RT PreMix; Intron, Seongnam, Korea), according the manufacturer's instructions. Specific primers for each gene ([Table 1](#T001){ref-type="table"}) were designed using Primer Express Software (Applied Biosystems, Carlsbad, CA, USA). The real-time reverse transcription polymerase chain reaction mixture consisted of 10 ng of reverse-transcribed total RNA, 167 nM forward and reverse primers, and PCR Master Mix (2X) in a final volume of 20 μL. Polymerase chain reaction was carried out in 48-well plates using the ABI Step One Plus Sequence Detection System (Applied Biosystems). All experiments were performed in triplicate.

###### 

Gene sequences for real-time reverse transcription polymerase chain reaction

  ------------------ ------------------------------ ---------------------------------
  Gene name          Sequences                      
                                                    
  Collagen type II   FOR: GAGTGGAAGAGCGGAGACTACTG   Chondrogenic genes
                     REV: CTCCATGTTGCAGAAGACTTTCA   
  SOX9               FOR: AGAGCGTTGCTCGGAACTGT      
                     REV: TCCTGGACCGAAACTGGTAAA     
  MMP1               FOR: GCCATTACTCACAACAATCCTC    Chondrogenic inflammatory genes
                     REV: ACACAATATCACCTTCCTCCTC    
  MMP13              FOR: AGGCCT TCAGAAAAGCCT TC    
                     REV: GAGCTGCTTGTCCAGGTTTC      
  GAPDH              FOR: TGAACGGGAAGCTCACTGG       
                     REV: TCCACCACCCTGTTGCTGTA      
  ------------------ ------------------------------ ---------------------------------

RESULTS
=======

Ginsenoside Rb~1~ increased cell viability
------------------------------------------

To examine effect of Rb~1~ on primary chondrocytes, the cell viability of the chondrocytes in the presence of Rb~1~ or H~2~O~2~ was determined. As shown in [Fig. 1](#F001){ref-type="fig"}A, the chondrocytes exposed to ginsenoside Rb~1~ at various concentrations (0 to 400 μM) did not exhibit significant toxicity over a period of 24 h. The percentage of viable cells was approximately 60% after a 24 h treatment with 500 μM H~2~O~2~. Thus, this treatment caused an approximately 40% loss of cell viability ([Fig. 1](#F001){ref-type="fig"}B).

![Cell viability of ginsenoside Rb~1~ in native chondrocytes and (H~2~O~2~)-treated chondrocytes. (A) Ginsenoside Rb~1~ (25 to 400 μM) was added to culture medium and rat articular chondrocytes were incubated for 24 h. (B) Culture medium pretreated for 1 h with ginsenoside Rb~1~ (50 and 100 μM) and incubated with 500 μM H~2~O~2~ for 24 h. Cell viability was assessed by the level of WST reduction and expressed as a percentage of viable untreated control cells grown in a defined medium. Data are expressed as mean±SEM of three independent experiments, \*p\<0.05.](grosbr-36-161-g001){#F001}

As shown in [Fig. 1](#F001){ref-type="fig"}B, a 1-hour pretreatment with ginsenoside Rb~1~ (100 μM) before the 24-hour incubation with H~2~O~2~ (500 μM) resulted in a higher cell viability (approximately 92%, *p*\<0.05) than H~2~O~2~ alone, indicating that 100 μM ginsenoside Rb~1~ may improve cell viability in the presence of H~2~O~2~. Therefore, all subsequent experiments were carried out using chondrocytes that had been pretreated for 1 h with 50 or 100 μM ginsenoside Rb~1~ and then exposed to 500 μM H~2~O~2~ for 24 h.

Ginsenoside Rb~1~ decreased the release of interleukin- 1β and tumor necrosis factor-α
--------------------------------------------------------------------------------------

IL-1β and TNF-α are pro-inflammatory cytokines that are induced by various cell stimulators. The absorbances measured by IL-1β and TNF-α ELISA kits were converted into percentages of the control absorbances.

![Inhibition of interleukin (IL)-1β and tumor necrosis factor (TNF)-α by ginsenoside Rb~1~ in hydrogen peroxide (H~2~O~2~)-treated chondrocytes. Culture medium was pretreated for 1 h with ginsenoside Rb~1~ (50 and 100 μM) and incubated with 500 μM H~2~O~2~ for 24 h. The release of IL-1β (A) and TNF-α (B) was measured in the culture supernatant using enzyme-linked immunosorbent assay. Data are expressed as mean±SEM of three independent experiments, \*p\<0.05, \*\*p\<0.01.](grosbr-36-161-g002){#F002}

As shown in [Fig. 2](#F002){ref-type="fig"}A and [2](#F002){ref-type="fig"}B, the absorbances of IL-1β and TNF-α in 500 μM H~2~O~2~-treated chondrocytes over 24 h increased approximately 130% and 364%, respectively, compared with non-treated chondrocytes. Pretreatment with ginsenoside Rb~1~ prior to incubation with 500 μM H~2~O~2~ for 24 h attenuated IL-1β (*p*\<0.05) and TNF-α (*p*\<0.01) production by approximately 100%, indicating that ginsenoside Rb~1~ attenuated the expression of the pro-inflammatory cytokines IL-1β and TNF-α in H~2~O~2~- treated chondrocytes.

Ginsenoside Rb~1~ suppressed nitric oxide production and inducible nitric oxide synthase activity
-------------------------------------------------------------------------------------------------

To further analyze the effect of Rb~1~ on nitric oxygen production and iNOS expression, cells were treated with Rb~1~ prior to H~2~O~2~ treatment. As shown in [Fig. 3](#F003){ref-type="fig"}A, ginsenoside Rb~1~ dose-dependently suppressed the NO production induced by H~2~O~2~ to approximately 250% at the highest concentration. The activity of iNOS was determined by immunoblotting ([Fig. 3](#F003){ref-type="fig"}B), which revealed the dose-dependent suppression of iNOS protein expression. These results indicate that ginsenoside Rb~1~ suppressed the production of NO (*p*\<0.01) and iNOS expression (*p*\<0.05) in H~2~O~2~-treated chondrocytes.

![Inhibition of nitric oxide (NO) production and inducible nitric oxide synthase (iNOS) protein analysis by ginsenoside Rb~1~ in hydrogen peroxide (H~2~O~2~)-treated chondrocytes. Culture medium was pretreated for 1 h with ginsenoside Rb~1~ (50 and 100 μM) and incubated with 500 μM H~2~O~2~ for 24 h. (A) The release of NO was measured in the culture supernatant using Griess reagent. (B) Immunoblotting for analysis of iNOS protein expression was performed as described in Materials and Methods. Data are expressed as mean±SEM of three independent experiments, \*p\<0.05, \*\*p\<0.01.](grosbr-36-161-g003){#F003}

Ginsenoside Rb~1~ suppressed cellular reactive oxygen species production
------------------------------------------------------------------------

The level of ROS in ginsenoside Rb~1~- and H~2~O~2~- treated chondrocytes was measured ([Fig. 4](#F004){ref-type="fig"}). The H~2~O~2~- treated cells showed the greatest increase in cellular ROS production (up to threefold) compared with the control. The cells exposed to the 1-hour pretreatment with 100 μM ginsenoside Rb~1~ and to H~2~O~2~ exhibited significantly suppressed production of ROS (down to threefold, *p*\<0.01) compared with the H~2~O~2~-only group. This result indicates that ginsenoside Rb~1~ significantly suppressed ROS production in H~2~O~2~-treated chondrocytes.

![Inhibition of reactive oxygen species (ROS) production by ginsenoside Rb~1~ in hydrogen peroxide (H~2~O~2~)-induced in chondrocytes. Chondrocytes were untreated or pretreated for 1 h with 50 and 100 μM ginsenoside Rb~1~ in the presence of 500 μM H~2~O~2~, and incubated for 0.5 h. Measurement of reactive oxygen species (ROS) production was performed as described in Materials and Methods section. Data are expressed as mean±SEM of three independent experiments, \*\*p\<0.01.](grosbr-36-161-g004){#F004}

Ginsenoside Rb~1~ improved chondrogenic genes and suppressed chondrogenic inflammatory genes
--------------------------------------------------------------------------------------------

H~2~O~2~ induced the expression of the chondrogenic inflammation factors MMP1 and MMP13 in chondrocytes. Additionally, H~2~O~2~ reduced the expression of type II collagen and SOX9, proteoglycans produced by chondrocytes with normal phenotypes. Thus, while H~2~O~2~ increased MMP1 and MMP13 expression and decreased type II collagen and SOX9 expression, chondrocytes pretreated with 100 μM ginsenoside Rb~1~ for 1 h prior to exposure to H~2~O~2~ showed a different gene expression pattern ([Fig. 5](#F005){ref-type="fig"}).

![Up-regulation of chondrogenic genes and down-regulation of inflammatory genes by ginsenoside in hydrogen peroxide (H~2~O~2~)-treated chondrocytes. Total RNA was obtained after 1 h pretreatment with 50 and 100 μM ginsenoside Rb~1~ in the presence of 500 μM H~2~O~2~-treated chondrocytes for 12 h. Real-time reverse transcription polymerase chain reaction analysis for chondrogenic genes (collagen type II and SOX9) and chondrogenic inflammatory genes (MMP1 and MMP13) was performed as described in Materials and Methods section. Results revealed that ginsenoside Rb~1~ increased chondrogenic gene expression and reduced chondrogenic inflammatory gene expression. Values are expressed as mean±SEM of three independent experiments, \*p\<0.05.](grosbr-36-161-g005){#F005}

After the addition of H~2~O~2~ for 12 h, cultures that had been pretreated with ginsenoside Rb~1~ exhibited decreased MMP1 and MMP13 expression levels (from 2.5 to 1.4 fold, *p*\<0.05, and 1.5 to 1.2 fold, *p*\<0.05, respectively) compared with cultures treated with H~2~O~2~ alone. The reductions in the expression levels of type II collagen and SOX9 were restored by pretreatment with 100 μM ginsenoside Rb~1~ compared with H~2~O~2~-only treated cells. These results indicate that ginsenoside Rb~1~ attenuated chondrogenic inflammation and improved the expression of proteoglycans that protect against H~2~O~2~- induced inflammation in rat chondrocytes.

DISCUSSION
==========

The abnormal maturation and ossification of articular chondrocytes play a central role in the pathogenesis of OA [@B015]. The pathology of OA involves various risk factors. Among these risk factors, oxidative stress and free radicals have been suggested to be important factors involved in OA [@B016].

Previously published studies have demonstrated that OA chondrocytes have a high lipoxidative activity [@B017]. Furthermore, the antioxidant capacity is diminished by aging, and increased lipid peroxidation has been observed in OA patients. These studies showed that oxidative stress plays an important role in the pathology of OA [@B018].

Excessive oxidative stress causes damage to DNA, lipids, and proteins and induces concomitant cellular damage [@B019]. H~2~O~2~ is a key intermediate in superoxide anion metabolism [@B003]. Several studies have shown that the activity of catalase (a free radical scavenger) is decreased in arthritic joints, including joints affected by OA [@B004]. Moreover, the major inflammatory cytokines IL-1β and TNF-α are highly expressed in OA. These cytokines downregulate the enzymatic antioxidant defenses in chondrocytes, resulting in the transient accumulation of H~2~O~2~ [@B005],[@B020]. Therefore, using antioxidants to protect against free radicals may be important the regulation of OA. In this study, H~2~O~2~ was employed to create an oxidative stress environment, and the effect of ginsenoside Rb~1~ on the regulation of various genes in H~2~O~2~-stimulated chondrocytes was evaluated. A previous study demonstrated the anti-oxidative and anti-inflammatory effects of ginsenoside Rb~1~ on 6-hydroxydopamine-treated human dopaminergic cells [@B021] and lipopolysaccharidetreated RAW 264.7 cells [@B022]. Our results revealed that ginsenoside Rb~1~ exhibits strong cytoprotective effects in a dose-dependent manner ([Fig. 1](#F001){ref-type="fig"}B). The levels of the H~2~O~2~-elicited proinflammatory cytokines IL-1β and TNF-α were significantly inhibited by ginsenoside Rb~1~ ([Fig. 2](#F002){ref-type="fig"}). Chondrocytes in the articular cavity might be the primary source of NO because they can generate more than any other cell type. Compared with the control, the chondrocytes in our *in vitro* model of OA produced significantly greater levels of NO ([Fig. 3](#F003){ref-type="fig"}A). NO is generated by activated iNOS during inflammatory processes [@B023]. Our results showed that H~2~O~2~-elicited NO, iNOS, and ROS production were significantly suppressed by ginsenoside Rb~1~ ([Figs. 3](#F003){ref-type="fig"} and [4](#F004){ref-type="fig"}). NO can induce intracellular signal transduction and inflammatory gene activation. Furthermore, NO can inhibit the synthesis of collagens and proteoglycans and can increase MMP activity in chondrocytes [@B024]. Pathologic changes include the decreased synthesis of ECM proteins, and the local accumulation of destructive enzymes was observed in H~2~O~2~-stimulated chondrocytes [@B025]. Drugs for the treatment of degenerative diseases of articular joints may be developed by increasing the synthesis of ECM molecules such as type II collagen and SOX9 and by inhibiting destructive enzymes such as MMPs [@B026]. Among members of the MMP superfamily, MMP1 and MMP13 have been shown to degrade type II collagen in OA. Our results revealed that ginsenoside Rb~1~ antagonized chondrogenic inflammatory genes (MMP1 and MMP13) and agonized chondrogenic genes (type II collagen and SOX8) to protect against H~2~O~2~-induced oxidative stress ([Fig. 5](#F005){ref-type="fig"}). These results suggest that ginsenoside Rb~1~ has potential for use as a therapeutic agent for OA due to this compound's anti-inflammatory effects.

Our study evaluated the cytoprotective effects of ginsenoside Rb~1~ on H~2~O~2~-stimulated chondrocytes. By detecting major proteins and inflammatory genes related to chondrogenic enzymes, we determined that ginsenoside Rb~1~ plays a protective role in articular chondrocytes. In conclusion, the present study demonstrated the protective effect of ginsenoside Rb~1~ on chondrocytes and provided new insight into the medicinal qualities of ginseng extracts. Our results suggest the possibility of including ginsenoside Rb~1~ in therapeutic interventions for OA.
